These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7804511)

  • 41. Urapidil. A reappraisal of its use in the management of hypertension.
    Dooley M; Goa KL
    Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urapidil in the treatment of hypertension.
    Rosendorff C
    Drugs; 1988; 35 Suppl 6():188-92. PubMed ID: 3042358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Course of blood pressure within the first 12 h of hypertensive urgencies.
    Hirschl MM; Herkner H; Bur A; Woisetschläger C; Gamper G; Frossard M; Laggner AN
    J Hypertens; 1998 Feb; 16(2):251-5. PubMed ID: 9535154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of mild hypertension with urapidil or captopril.
    Rosenthal J; Schäfer N; Haerlin R; Wurst W; Solleder P
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):233S-236S. PubMed ID: 3046630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative clinical study of the antihypertensive effects of urapidil versus diazoxide in patients with severe arterial hypertension].
    Gasparović V; Vrhovac B; Rumboldt Z; Ivanković D
    Lijec Vjesn; 1986; 108(11-12):494-6. PubMed ID: 3553816
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies.
    Hirschl MM; Binder M; Bur A; Herkner H; Müllner M; Woisetschläger C; Laggner AN
    Intensive Care Med; 1997 Aug; 23(8):885-8. PubMed ID: 9310807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of hypertensive crisis with ebrantil (urapidil)].
    Mleczko-Nycz Z; Kokot F
    Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
    [No Abstract]   [Full Text] [Related]  

  • 48. [Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
    Liebau H; Wurst W; Harder I; Solleder P
    Fortschr Med; 1988 Nov; 106(32):651-4. PubMed ID: 3148534
    [No Abstract]   [Full Text] [Related]  

  • 49. [Lipid metabolism in hypertensive therapy. Measurements of electrolytes, lipids and lipoproteins in blood of normal and hypertensive individuals during repeated administration of Ebrantil].
    Mertz DP; Dittmann EC
    MMW Munch Med Wochenschr; 1983 May; 125(18):389-91. PubMed ID: 6406877
    [No Abstract]   [Full Text] [Related]  

  • 50. [Urapidil as a basic drug in severe hypertension].
    Thuma G
    Fortschr Med; 1986 Jun; 104(22):457-460. PubMed ID: 3744250
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of hypotensive drugs on serum levels of lipids and lipoproteins in humans].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1988 Oct; 43(44):1422-4. PubMed ID: 3252208
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of trimazosin on serum lipid profiles in hypertensive patients.
    Singleton W; Taylor CR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1265-8. PubMed ID: 6356856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Permeation of the blood-brain barrier by urapidil and its influence on intracranial pressure in man in the presence of compromised intracranial dynamics.
    Anger C; van Aken H; Feldhaus P; Wüsten R; Konig H; Krahling KH; Lawin P
    J Hypertens Suppl; 1988 Dec; 6(2):S63-4. PubMed ID: 3230473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Metabolic and cardiovascular profile in antihypertensive treatment with urapidil].
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Therapie; 1990; 45 Suppl 2():219-27. PubMed ID: 2187268
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of hypertension with urapidil].
    Fetkovská N; Dzúrik R
    Cas Lek Cesk; 1985 Oct; 124(41-42):1292-5. PubMed ID: 3902242
    [No Abstract]   [Full Text] [Related]  

  • 56. [Does urapidil attenuate the hypertensive response to tracheal intubation at the time of general anesthesia?].
    Quéré JF; Ozier Y; Bringier J; Morot B; Bernard D; Pigot B; Conseiller C
    Cah Anesthesiol; 1990 Nov; 38(5):343-4. PubMed ID: 2285871
    [No Abstract]   [Full Text] [Related]  

  • 57. [Control of arterial pressure in 86 patients treated with Urapidil both during the intra- and postoperative period].
    Paulin L; Bonezzi C; Bonacina M; Miotti D; De Falco A; Demartini L; Dossena ; Rebecchi
    Minerva Anestesiol; 1990 Sep; 56(9):745. PubMed ID: 2274178
    [No Abstract]   [Full Text] [Related]  

  • 58. Urapidil-induced increase of the intracranial pressure in head-trauma patients.
    Singbartl G; Metzger G
    Intensive Care Med; 1990; 16(4):272-4. PubMed ID: 2358563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical effects of urapidil on red cell membrane ion transport systems in a population of elderly essential hypertensives.
    Antonicelli R; Balducci E; Lipponi G; Lucantoni C; Gaetti R; Paciaroni E
    Postgrad Med J; 1991 Mar; 67(785):252-5. PubMed ID: 2062772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profile of trimazosin: an effective and safe antihypertensive agent.
    Taylor CR; Leader JP; Singleton W; Munster EW; Falkner FC; O'Neil JA
    Am Heart J; 1983 Nov; 106(5 Pt 2):1269-81. PubMed ID: 6227228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.